Literature DB >> 8011662

cDNA and deduced amino acid sequences of a human colon dihydrodiol dehydrogenase.

P J Ciaccio1, K D Tew.   

Abstract

A 1.24 kbp cDNA encoding a human colon HT29 cell dihydrodiol dehydrogenase of 323 amino acid residues (M(r) 36,735) has been isolated and sequenced. The deduced amino acid sequence was 97%, 81%, and 76% identical to human liver dihydrodiol dehydrogenase (also called bile acid binder), human liver chlordecone reductase, and bovine lung prostaglandin f synthase, respectively. It was 98% identical in 990 bp overlap with the nucleotide sequence of human liver pseudochlordecone reductase. Northern blots revealed that dihydrodiol dehydrogenase(s) were markedly induced in HT29 colon cells by treatment with the Michael acceptor agent ethacrynic acid.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8011662     DOI： 10.1016/0005-2728(94)90144-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


  10 in total

Review 1.  Adaptive response to glutathione S-transferase inhibitors.

Authors:  P J Ciaccio; K D Tew
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase.

Authors:  L S Ireland; D J Harrison; G E Neal; J D Hayes
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

3.  Aldo-Keto Reductase Regulation by the Nrf2 System: Implications for Stress Response, Chemotherapy Drug Resistance, and Carcinogenesis.

Authors:  Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2016-11-16       Impact factor: 3.739

4.  Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.

Authors:  T O'connor; L S Ireland; D J Harrison; J D Hayes
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

5.  Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA.

Authors:  H Shiraishi; S Ishikura; K Matsuura; Y Deyashiki; M Ninomiya; S Sakai; A Hara
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

6.  Roles of the C-terminal domains of human dihydrodiol dehydrogenase isoforms in the binding of substrates and modulators: probing with chimaeric enzymes.

Authors:  K Matsuura; A Hara; Y Deyashiki; H Iwasa; T Kume; S Ishikura; H Shiraishi; Y Katagiri
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

7.  Substrate specificity of an aflatoxin-metabolizing aldehyde reductase.

Authors:  E M Ellis; J D Hayes
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

8.  Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells.

Authors:  A Hara; K Matsuura; Y Tamada; K Sato; Y Miyabe; Y Deyashiki; N Ishida
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

Review 9.  Aldo-keto reductase (AKR) superfamily: genomics and annotation.

Authors:  Rebekka D Mindnich; Trevor M Penning
Journal:  Hum Genomics       Date:  2009-07       Impact factor: 4.639

Review 10.  Aldo-Keto Reductases and Cancer Drug Resistance.

Authors:  Trevor M Penning; Sravan Jonnalagadda; Paul C Trippier; Tea Lanišnik Rižner
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 18.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.